2. [...] The "extra" spending in medicine drives innovations so we have better drugs & procedures etc.
That's what many doctors (also in Europe) argue. An argument against that could be based in Ben Goldacre's Bad Pharma depressing review of the flow of money in relation to how medical trials are used to decide what's better.
That's what many doctors (also in Europe) argue. An argument against that could be based in Ben Goldacre's Bad Pharma depressing review of the flow of money in relation to how medical trials are used to decide what's better.